Syphilis Screening Blood Test in Kathmandu Serological testing explained: screening, confirmation, and interpretation

Overview

Syphilis, caused by the bacterium Treponema pallidum, cannot be diagnosed by symptoms alone because its early stages mimic many other conditions and later stages can be silent for years. Diagnosis relies on serological blood tests that detect antibodies to the bacterium. Modern testing uses a two-step algorithm: a screening test followed by a confirmatory test.

The two main families of tests serve different purposes. Non-treponemal tests such as RPR and VDRL measure antibody activity and produce titers that track disease activity and treatment response. Treponemal tests such as TPHA and FTA-ABS confirm exposure to T. pallidum and typically remain positive for life. Using both families together minimizes false positives and false negatives.

In Nepal, syphilis remains a significant public health concern, particularly among pregnant women, sex workers, and men who have sex with men. Screening is recommended for pregnant women at first antenatal visit, people with multiple partners, men who have sex with men, HIV-positive individuals, and anyone with symptoms of genital ulcers or rash.

This guide explains how syphilis blood testing works, which tests are used, how results are interpreted, what the window period means for timing, and how affordable confidential testing is available at Thamel Clinic in Kathmandu.

The Two-Test Algorithm Explained

Syphilis testing follows a standardized two-step process. First, a non-treponemal screening test such as RPR or VDRL is performed. If this is reactive, a treponemal confirmatory test such as TPHA or FTA-ABS is done to verify the result. This algorithm is recommended because no single test is perfect; combining tests maximizes accuracy.

The screening test is sensitive but less specific, meaning it can produce false positives from other conditions like autoimmune diseases or pregnancy. The confirmatory test is highly specific for T. pallidum antibodies. A positive screen with positive confirmation indicates syphilis infection, while a positive screen with negative confirmation suggests a false positive.

• Step 1: Non-treponemal screen (RPR or VDRL)
• Step 2: Treponemal confirmation (TPHA or FTA-ABS)
• Positive screen + positive confirm = syphilis infection
• Positive screen + negative confirm = likely false positive
• Negative screen usually rules out infection
• Quantitative titers track disease activity and treatment response

Understanding Each Test Type

Non-treponemal tests (RPR, VDRL) detect antibodies that are produced in response to T. pallidum infection but are not specific to the organism. They produce quantitative titers that correlate with disease activity. After treatment, titers should decline; failure to decline may indicate treatment failure or reinfection.

Treponemal tests (TPHA, FTA-ABS) detect antibodies specific to T. pallidum antigens. Once positive, they typically remain positive for life, even after successful treatment. They confirm exposure but cannot distinguish active from past infection, which is why non-treponemal titers are needed for monitoring.

• RPR: Rapid Plasma Reagin, commonly used screening test
• VDRL: Venereal Disease Research Laboratory test, similar to RPR
• TPHA: Treponema pallidum Hemagglutination Assay, confirmatory test
• FTA-ABS: Fluorescent Treponemal Antibody Absorption, highly specific confirmatory
• Non-treponemal titers decline after treatment
• Treponemal tests remain positive for life

Window Period and Timing

The window period is the time between exposure to T. pallidum and when tests can reliably detect infection. For syphilis, this is typically three to six weeks, though it can be up to three months in some cases. Testing too early may produce false negative results even if infection is present.

If you have had a potential exposure and test negative, repeat testing after the window period is recommended. For high-risk exposures, testing at six weeks and three months provides the most reliable results. Your clinician will advise on appropriate timing based on your specific situation.

• Window period is typically 3-6 weeks after exposure
• Can be up to 3 months in some cases
• Testing too early may produce false negatives
• Repeat testing recommended if initial test is negative
• 6-week and 3-month testing for high-risk exposures
• Clinical symptoms can appear before tests turn positive

What Your Results Mean

A negative screening test usually means no detectable syphilis infection, subject to window period considerations. A positive screening test requires confirmation with a treponemal test. If both are positive, you have syphilis and need treatment. If screen is positive but confirm is negative, the result is likely a false positive.

Quantitative titers from RPR or VDRL provide additional information. Higher titers suggest more active disease. After treatment, titers should decline over months. A fourfold decline is considered adequate response. Stable low titers may indicate serofast status, which does not require retreatment.

• Negative screen usually rules out infection
• Positive screen + positive confirm = syphilis infection
• Positive screen + negative confirm = false positive likely
• Quantitative titers track disease activity
• Titer decline after treatment confirms response
• Serofast state possible after successful treatment

Syphilis Blood Testing Services

Prices are indicative in NPR. Confirm current laboratory rates at booking.

Related Services & Guides